See also this year's filing and all EDGAR filings for this company.
PDF Report 0001513525_2019_Adial_Pharmaceuticals_INC.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001513525, Adial Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 4,692,550 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 6,735 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 0 |
| 4 | LiabilitiesCurrent | 257,974 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 6,618,763 |
| 9 | ResearchAndDevelopmentExpense | 368,459 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -4,644,156 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 4,699,285 |
| 1 | Liabilities | 257,974 |
| 2 | Expenses | 6,987,222 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 4,441,311 |
| 5 | NetIncome | -11,631,378 |
| 6 | ComprehensiveNetIncome | -11,631,378 |
| 7 | BaseVar | 8,294,318 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -0.786 |
| 9 | EconomicCapitalRatio | 1.34 |
Edgar->Model Mapping
Feature Distribution
